Overview

French National Registry of Children Born Small for Gestational Age Treated With Somatropin

Status:
Completed
Trial end date:
2018-10-09
Target enrollment:
0
Participant gender:
All
Summary
This study is conducted in Europe. The aim of the study is to describe the patient population and therapeutic practices (study phase I), assess efficacy on growth and adult height and assess tolerance of somatropin (Norditropin® SimpleXx®) (study phase II)
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Novo Nordisk A/S
Criteria
Inclusion Criteria:

- Born small for gestational age